A detailed history of Kbc Group Nv transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,833 shares of AVNS stock, worth $51,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,833
Previous 1,738 63.0%
Holding current value
$51,050
Previous $35,000 94.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$19.21 - $24.69 $21,034 - $27,035
1,095 Added 63.0%
2,833 $68,000
Q4 2023

Feb 13, 2024

SELL
$17.64 - $22.99 $32,739 - $42,669
-1,856 Reduced 51.64%
1,738 $39,000
Q3 2023

Feb 15, 2024

SELL
$19.93 - $26.31 $36,990 - $48,831
-1,856 Reduced 51.64%
1,738 $35,000
Q2 2023

Feb 15, 2024

SELL
$22.53 - $30.98 $11,963 - $16,450
-531 Reduced 12.87%
3,594 $92,000
Q1 2023

Feb 14, 2024

SELL
$26.92 - $31.75 $14,294 - $16,859
-531 Reduced 12.87%
3,594 $107,000
Q1 2023

May 04, 2023

SELL
$26.92 - $31.75 $14,294 - $16,859
-531 Reduced 12.87%
3,594 $107,000
Q3 2022

Feb 15, 2024

BUY
$21.56 - $29.59 $51,463 - $70,631
2,387 Added 137.34%
4,125 $90,000
Q2 2022

Feb 14, 2024

BUY
$24.87 - $34.68 $15,891 - $22,160
639 Added 18.33%
4,125 $113,000
Q2 2022

Jul 26, 2022

BUY
$24.87 - $34.68 $15,891 - $22,160
639 Added 18.33%
4,125 $113,000
Q1 2022

Feb 14, 2024

BUY
$28.87 - $35.77 $56,238 - $69,679
1,948 Added 126.66%
3,486 $117,000
Q1 2022

May 06, 2022

BUY
$28.87 - $35.77 $56,238 - $69,679
1,948 Added 126.66%
3,486 $117,000
Q4 2021

Feb 14, 2024

SELL
$29.25 - $36.02 $5,850 - $7,204
-200 Reduced 11.51%
1,538 $53,000
Q3 2021

Nov 10, 2021

BUY
$31.2 - $38.5 $47,985 - $59,213
1,538 New
1,538 $48,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $838M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.